Successful treatment of cutaneous sarcoidosis with deucravacitinib, a selective TYK2 inhibitor

Shranjeno v:

Bibliografske podrobnosti
Principais autores:	Henry O. Herrera, BS, Carol Sanchez, MD, Gabrielle Minor, PA-C, Gregory J. Fulchiero, Jr., MD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2026-01-01
Serija:	JAAD Case Reports
Teme:	cutaneous sarcoidosis deucravacitinib immunomodulation JAK-STAT pathway sarcoidosis TYK2 inhibitor
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2352512625005958
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki